Summary A large number of cells containg subunit a of blood coagulation Factor XIII (FXIII) was detected by immunoperoxidase staining in lymph nodes with Hodgkin's disease. These relatively large, multipolar, mononuclear cells were often found in the immediate vicinity of malignant Hodgkin's cells. Intensive characterization of these cells carried out by immunofluorescent and enzymecytochemical techniques in double-and triple-labelling systems on the same sections clearly demonstrated that they represent tumourassociated macrophages (TAMs). FXIII containing-cells showed a-naphtyl acetate esterase (ANAE) positivity, and were labelled by monoclonal anti-Leu M3 antibody, a monocyte/macrophage marker, but not at all or only very weakly by anti-HLA-DR. Neither alkaline phosphatase (ALP) nor adenosine triphosphatase (ATPase) activity could be detected in these cells and surprisingly, they were consistently negative for acid phosphatase (AcP) as well. The presence of FXIII subunit a in tumour-associated macrophages suggests that this cell type might have an important role in the stabilization of fibrin deposits around tumour cells.
Fibrin deposition is a rather frequent finding in spontaneously-arising as well as transplantable human and animal tumours and has been implicated in various aspects of tumour growth and metastasis (Rickles & Edwards, 1983; Dvorak et al., 1983) . Though most or perhaps all malignant cells possess procoagulant activities (O'Meara, 1958; Gordon et al., 1975; Gordon & Cross, 1981;  Semeraro & Donati, 1981) that can activate the coagulation cascade, it is becoming increasingly evident that tumour-associated macrophages (TAMs) are also involved in intra-tumoral fibrin formation (Edwards et al., 1981; Evans, 1982; Lorenzet et al., 1983; Key, 1983) .
Macrophages or, in view of their heterogeneity (Hopper et al., 1979; Poulter et al., 1983) , certain of their subsets could contribute to extravascular clotting by two mechanisms. (i) By expressing tissue factor activity they can initiate the extrinsic coagulation pathway (Rickles & Edwards, 1983; Dvorak et al., 1983; Lorenzet et al., 1983) . (ii) They contain a number of clotting factors which, if secreted or released from damaged cells into the interstitial space, provide all the components necessary for extrinsic thrombin formation. The production of vitamin K-dependent clotting factors (Factor II, VII, IX, X) and Factor V by macrophages has been well established (Osterud et al., 1980; Lindahl et al., 1982; van Dam-Mieras et al., 1985; Chapman et al., 1985) . Most recently the presence of subunit a of Factor XIII (FXIII), the enzymatically-active constituent of fibrin stabilizing factor has also been demonstrated in human peripheral blood monocytes and peritoneal macrophages in our laboratory. Independently, these results have been confirmed by Henriksson et al. (1985) . FXIII delivered by macrophages into the tumour stroma might have an important role in the stabilization of fibrin formed extravascularly and in its activated form as a transglutaminase it might exert other biological functions as well. Thus, it was interesting to see if TAMs or certain subsets of them contain FXIII.
The presence of fibrin deposits in lymph nodes with Hodgkin's disease is a general observation (Harris et al., (1982; Dvorak et al., 1983) and in these lymph nodes macrophage-like cells prevail over all other cell types in areas rich in fibrillar intercellular substance (Stiller & Katenkamp, 1978; Hansmann & Kaiserling, 1981 . Antigen-antibody reaction was detected by biotinylated anti-rabbit IgG and avidin-biotinylated peroxidase complex (Vectastain ABC kit) (Vector Laboratories, Burlingame, CA). The specific peroxidase activity was visualized by 0.05% 3,3'-diaminobenzidine tetrahydrochloride (DAB) (Sigma Co., St As a third step, one of the following enzymes was detected: oc-napthyl acetate esterase (ANAE) (Mueller et al., 1975) , acid phosphatase (AcP) (Poulter et al., 1983) , adenosine triphosphatase (ATPase) (Poulter et al., 1983 ) and alkaline phosphatase (ALP) (Mason & Woolston, 1982) .
In the case of negative control slides in the enzymecytochemical reactions either the substrate was omitted from the incubation medium, or before development of an enzyme reaction the appropriate enzyme activity was blocked according to the recommendation of Poulter et al. (1983) . Finally, sections were remounted in 50% glycerol in PBS and the fields of which photographs had been previously taken were identified in normal light microscope (Figure 3a, b) . This fact together with their definite ANAE positivity (Figure 4b, c) clearly identifies FXIII containing-cells as members of the macrophage family. These cells were predominantly negative for HLA-DR though occasionally very weak positive staining could also be detected (Figures 2, 4a, b) . ALP (Figure 5a, b) and ATPase activities (not shown) could not be detected in FXIII containing cells and surprisingly, they were consistently negative for AcP (Figure 6a, b) , as well. The presence of HLA-DR or AcP positive but FXIII negative cells with macrophage-like morphological features clearly indicates that FXIII is expressed only in a certain subset of TAMs.
In contrast to lymph nodes with Hodgkin's disease, in reactive lymph nodes, FXIII containing cells were localized almost exclusively in perivascular connective tissue and in subcapsular or medullary sinuses. Macrophages in follicles of reactive lymph nodes identified by strong ANAE reaction were consistently negative for FXIII subunit a and only a few positive cells could be detected in the interfollicular areas (not shown). A detailed characterization of FXIII containing-cells in reactive lymph nodes is published elsewhere (Nemes et al., 1986) .
Discussion
Plasma FXIII, like most other clotting factors circulates as a zymogen. It is a tetrameric protein consisting of two types of subunits (a2b2). The potential enzymatic site is located on subunit a which can assume an active configuration only following proteolytic cleavage by thrombin and Ca2 + induced dissociation from the inhibitory b subunit (see Muszbek & Laki, 1984 for review). It has been known for a long time that subunit a but not b also exists as an intracellular protein in platelets (Buluk, 1955) , megakaryocytes (Kiesselbach & Wagner, 1972) and placenta (Bohn & Schwick, 1971) . As mentioned earlier the existence of subunit a in monocytes has also been verified and these cells retain their FXIII content following differentiation into peritoneal macrophages (Ad'any et al., 1985) . Furthermore, it was shown that FXIII containing cells in the placenta are also of macrophage origin (Adany & Muszbek, submitted for publication) .
In this study a cell type expressing FXIII subunit a was detected in lymph nodes with Hodgkin's disease. The morphological appearance of FXIII containing cells indicated that they belong to TAMs, thus combinations of immuno-and enzyme-histochemical reactions -generally used for identification and/or phenotyping of macrophages -were applied to characterize them. Their macrophage nature was clearly demonstrated by Leu M3 and ANAE positivity. At the same time negative reactions were found for HLA-DR, AcP, ALP and ATPase.
The above results strongly suggest that this FXIII containing-TAM cell type is not identical with any of the macrophage cell types characterized earlier in normal human lymph node. This conclusion is clearly supported by the following data: (i) FXIII containing-macrophages are not identical with interdigitating reticular cells and dentritic cells of lymph node because the latters are strongly positive for HLA-DR and ATPase (Janossy et al., 1980; Stein et al., 1980; Poulter et al., 1983) . (ii) They differ from sinus histiocytes of normal lymph node and from inflammatory macrophages, as well as by the absence of AcP activity (Poulter et al., 1983) . (iii) Being ALP negative they may not be interpreted as fibroblastic reticulum cells (Chilosi et al., 1981) . On the other hand, FXIII containing-cells in lymph nodes with Hodgkin's disease are not even identical with other FXIII containing-cells of normal lymph nodes which occur in the connective tissue of capsule and in the sinus (Nemes et al., 1986) . HLA-DR positivity of connective tissue histiocytes as well as the intensive AcP reaction of sinus macrophages clearly distinguish the latter cell types from FXIII containing-TAMs. Different types of macrophages originate from a common bone marrow precursor (van Furth, 1981) but owing to an intricate differentiation program associated with the expression and disappearance of various gene products (Dimitriu-Bona et al., 1983) they show an extreme phenotypic and functional diversity. In consideration of this fact we believe that FXIII containing-TAMs are a subset of macrophages differentiated from blood monocytes for special function(s) related to malignant cell proliferation. Independently from FXIII containing-macrophages some AcP positive macrophage-like cells were also detected. This finding together with the presence of HLA-DR positive, but FXIII negn-itive cclls in lymph nodes with Hodgkin's diseaise support the possibility that TAMs are to be considered as an inhomogeneous cell population.
Extravascular fibrin deposition occurs in the stroma and at host-tumour interface in most or perhaps all malignant neoplasms (Dvorak et al., 1983) . The pathological significance and the origin of fibrin deposits has not been sufficiently explored. Most of the available clinical and experimental data, however, tend to support* the view that the activation of clotting system is beneficial for both tumour progression and metastasis formation. Mostly on the basis of theoretical considerations the following hypotheses have been proposed for the pathogenic role of fibrin formed between and around tumour cells: (1) it might have a barrier function and interferes with the host's immune response, (2) it could stimulate tumour angiogenesis, (3) it may have a role in the implantation of circulating tumour cells at metastatic sites (Dvorak et al., 1983 ). An important role for FXIII -fibrin stabilizing factor -in any of the above mechanisms seems rather obvious. By forming fibrinolysisresistant fibrin meshwork and crosslinking fibnrllar intercellular matrix components, FXIII might support the barrier function or might even be essential to it. The process of angiogenesis and fibroplasia during tumour growth and wound healing has been compared (Dvorak et al., 1983) and it is well known that wound healing is highly impaired in FXIII deficient patients (Duckert, 1972) . A possible direct effect of FXIII on cell proliferation, as observed in the case of fibroblasts (Beck et al., 1961) , might also have some implications for tumour growth. A further possibility concerns the transglutaminase nature of activated FXIII. As a transglutaminase it can attach host proteins covalently to the membrane of tumour cells and mask their putative 'non-self' character resulting in increased immune resistance. The latter idea is supported by data showing that attachment of fibrinogen to the membrane of YPC-1 plasmocytoma cells by tissue transglutaminase results in an inhibition of cell mediated cytotoxic response (Hunyadi et al., 1981) .
In tumours FXIII could get into the interstitial space from two possible sources. It may leak from blood vessels together with other plasma proteins due to enhanced microvascular permeability or it may originate from the TAM subgroup described here by active secretion and/or release following cell destruction. However, this question has not been addressed experimentally. Clearly, further investigations are to be carried out to test the above hypotheses and establish the role of FXIII as well as FXIII containing-TAMs in the progression of malignant tumours.
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